BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8950124)

  • 1. Ancrod: the use of snake venom in the treatment of patients with heparin-induced thrombocytopenia and thrombosis undergoing coronary artery bypass grafting: nursing management.
    Lathan LO; Staggers SL
    Heart Lung; 1996; 25(6):451-60; quiz 461-2. PubMed ID: 8950124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis.
    Teasdale SJ; Zulys VJ; Mycyk T; Baird RJ; Glynn MF
    Ann Thorac Surg; 1989 Nov; 48(5):712-3. PubMed ID: 2818066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ancrod infusion for anticoagulation during and after PTCA in a patient with heparin-induced thrombocytopenia.
    Moore JA; Burket MW; Puri S; Temesy-Armos P; Lachant N; Skeel R
    Cathet Cardiovasc Diagn; 1994 Jul; 32(3):286-7. PubMed ID: 7954782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy.
    Smith RE; Townsend GE; Berry BR; Bowen T
    Ann Pharmacother; 1996 May; 30(5):476-80. PubMed ID: 8740327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparinless cardiopulmonary bypass with ancrod.
    O-Yurvati AH; Laub GW; Southgate TJ; McGrath LB
    Ann Thorac Surg; 1994 Jun; 57(6):1656-8. PubMed ID: 8010823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia and thrombosis: presentation after cardiopulmonary bypass.
    Munver R; Schulman IC; Wolf DJ; Rosengart TK
    Ann Thorac Surg; 1994 Dec; 58(6):1764-6. PubMed ID: 7979757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ancrod: understanding the agent.
    Illig KA; Ouriel K
    Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.
    Demers C; Ginsberg JS; Brill-Edwards P; Panju A; Warkentin TE; Anderson DR; Turner C; Kelton JG
    Blood; 1991 Nov; 78(9):2194-7. PubMed ID: 1932741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod.
    Cole CW; Fournier LM; Bormanis J
    Can J Surg; 1990 Jun; 33(3):207-10. PubMed ID: 2190683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
    Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin-induced thrombosis treated with ancrod.
    Brennan MB; MacKean GL
    Can J Surg; 1994 Apr; 37(2):161-4. PubMed ID: 8156472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition, diagnosis, and management of heparin-induced thrombocytopenia and thrombosis.
    Smoot EC; Marx A; Weiman D; Deitcher SR
    Plast Reconstr Surg; 1999 Feb; 103(2):559-65. PubMed ID: 9950545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin-induced thrombocytopenia after on-pump coronary artery bypass grafting].
    Kigawa I; Okamura Y; Fukuda S; Miyairi T
    Kyobu Geka; 2010 Jun; 63(6):442-5. PubMed ID: 20533732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic changes in a patient with heparin-induced thrombocytopenia who underwent cardiopulmonary bypass after ancrod defibrinogenation.
    Spiess BD; Gernsheimer T; Vocelka C; Chandler WL; Benak A; Joy JV; Wright I; Hofer BO
    J Cardiothorac Vasc Anesth; 1996 Dec; 10(7):918-21. PubMed ID: 8969402
    [No Abstract]   [Full Text] [Related]  

  • 15. Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin-associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass.
    Spiekermann BF; Lake CL; Rich GF; Humphries JE
    Anesthesiology; 1994 Mar; 80(3):686-8. PubMed ID: 8141466
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.
    Kanagasabay RR; Unsworth-White MJ; Robinson G; Bevan D; Farnsworth G; Haxby EJ; Smith EE
    Ann Thorac Surg; 1998 Aug; 66(2):567-9. PubMed ID: 9725413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate vein graft thrombectomy for acute occlusion after coronary artery bypass grafting.
    Saltman AE; Dzik WH; Levitsky S
    Ann Thorac Surg; 1999 Jun; 67(6):1775-6. PubMed ID: 10391290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of heparin-induced thrombocytopenia and thrombosis.
    Green RM
    Semin Vasc Surg; 1996 Dec; 9(4):292-5. PubMed ID: 8958605
    [No Abstract]   [Full Text] [Related]  

  • 19. In situ right ventricular thrombus secondary to heparin induced thrombocytopenia.
    Dion D; Dumesnil JG; LeBlanc P
    Can J Cardiol; 1989 Sep; 5(6):308-10. PubMed ID: 2790577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia after coronary artery bypass grafting with cardiopulmonary bypass: report of a case.
    Ishida K; Imamaki M; Ishida A; Shimura H; Miyazaki M
    Surg Today; 2004; 34(12):1041-3. PubMed ID: 15580389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.